Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
코로나19 이후 합병증 및 신경학적 징후의 특성화 및 바이오마커 분석
Article
[키워드] age
All participants
amyloid beta
analyses
antibody
characterization
co-morbidity
collected
Comorbidities
Complication
controls
CoV
COVID-19
COVID-19 infection
cytokine
Cytokines
demonstrated
dysfunction
Exosome
explain
Extracellular
had more
IL-4
IL6
individual
Infection
initial
Longitudinal studies
longitudinal study
manifestation
marker
MONITOR
morbidity
nCoV
neurodegeneration
neurogranin
Neuroinflammation
neurologic
neurological
neurological problem
neurological problems
Neurological symptom
Neurological symptoms
neuronal
pandemic
participant
Participants
plasma
plasma biomarker
Plasma cytokine
positive correlation
Protein
Proteins
recovering from COVID-19
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 pandemic
Severe infection
severity
significantly increased
systemic effects
the SARS-CoV-2
Vesicle
volunteers
was increased
[DOI] 10.3390/cells10020386 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cells10020386 PMC 바로가기 [Article Type] Article